Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ra Medical Systems, Inc. (RMED)

3.27   0 (0%) 01-27 16:00
Open: 3.26 Pre. Close: 3.27
High: 3.2945 Low: 3.13
Volume: 82,104 Market Cap: 7(M)

Technical analysis

as of: 2023-01-27 4:47:35 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 6.61     One year: 8.46
Support: Support1: 3.08    Support2: 2.57
Resistance: Resistance1: 5.66    Resistance2: 7.25
Pivot: 3.94
Moving Average: MA(5): 3.37     MA(20): 4.49
MA(100): 4.88     MA(250): 11.41
MACD: MACD(12,26): -0.4     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 5.8     %D(3): 7
RSI: RSI(14): 40.2
52-week: High: 42  Low: 0.28
Average Vol(K): 3-Month: 1,623 (K)  10-Days: 165 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ RMED ] has closed above bottom band by 33.5%. Bollinger Bands are 44.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 15 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.3 - 3.32 3.32 - 3.33
Low: 3.09 - 3.11 3.11 - 3.13
Close: 3.24 - 3.27 3.27 - 3.3

Company Description

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Headline News

Mon, 23 Jan 2023
2023-01-23 | NYSEAM:RMED | Press Release | Ra Medical ... - Stockhouse

Tue, 17 Jan 2023
Ra Medical Systems Realigns Its Board of Directors - Business Wire

Fri, 13 Jan 2023
Is RA Medical Systems Inc (RMED) Stock a Smart Value Friday? - InvestorsObserver

Thu, 12 Jan 2023
Is RA Medical Systems Inc (RMED) Stock Worth a Buy Thursday? - InvestorsObserver

Tue, 13 Dec 2022
Should You Add RA Medical Systems Inc (RMED) Stock to Your Portfolio Tuesday? - InvestorsObserver

Wed, 07 Dec 2022
RA Medical Systems Inc (RMED) is down 7.21% Wednesday In Premarket Trading - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 7 (M)
Shares Float 7 (M)
% Held by Insiders 2.1 (%)
% Held by Institutions 3 (%)
Shares Short 417 (K)
Shares Short P.Month 477 (K)

Stock Financials

EPS -6.66
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.05
Profit Margin (%) 0
Operating Margin (%) -766
Return on Assets (ttm) -56.6
Return on Equity (ttm) -115
Qtrly Rev. Growth -92.6
Gross Profit (p.s.) -0.16
Sales Per Share 0.59
EBITDA (p.s.) -4.35
Qtrly Earnings Growth 0
Operating Cash Flow -31 (M)
Levered Free Cash Flow -18 (M)

Stock Valuations

PE Ratio -0.5
PEG Ratio 0
Price to Book value 1.06
Price to Sales 5.52
Price to Cash Flow -0.74

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.